tirzepatide taken off shortage list GLP-1 Drugs: FDA Removes Lilly's Zepbound® and Mounjaro® (tirzepatide injection) from its Drug FDA declares Mounjaro, Zepbound shortage

A 2023 study found social media reports of GLP-1 receptor agonists like Ozempic causing insomnia, but it also found reports of improved insomnia

This brings the two injections closer together than usual, which is safe and preferred over skipping entirely

While semaglutide offers significant advantages, it must be used under medical supervision to ensure safety and effectiveness

Understanding these numbers helps set realistic expectations for treatment

By the fourth decade of life, we are making 30% less glutathione

If youve seen posts about hair loss caused by semaglutide, Ozempic, or Wegovy, the pattern is fairly consistent: shedding starts weeks to a few months after the trigger